Your browser doesn't support javascript.
loading
Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia.
Döhner, Konstanze; Thiede, Christian; Jahn, Nikolaus; Panina, Ekaterina; Gambietz, Agnes; Larson, Richard A; Prior, Thomas W; Marcucci, Guido; Jones, Dan; Krauter, Jürgen; Heuser, Michael; Voso, Maria Teresa; Ottone, Tiziana; Nomdedeu, Josep F; Mandrekar, Sumithra J; Klisovic, Rebecca B; Wei, Andrew H; Sierra, Jorge; Sanz, Miguel A; Brandwein, Joseph M; de Witte, Theo; Jansen, Joop H; Niederwieser, Dietger; Appelbaum, Frederick R; Medeiros, Bruno C; Tallman, Martin S; Schlenk, Richard F; Ganser, Arnold; Serve, Hubert; Ehninger, Gerhard; Amadori, Sergio; Gathmann, Insa; Benner, Axel; Pallaud, Celine; Stone, Richard M; Döhner, Hartmut; Bloomfield, Clara D.
Affiliation
  • Döhner K; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Thiede C; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Jahn N; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Panina E; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Gambietz A; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.
  • Larson RA; Department of Medicine and Comprehensive Cancer Research Center, University of Chicago, Chicago, IL.
  • Prior TW; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Marcucci G; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Jones D; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Krauter J; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Heuser M; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Voso MT; Department of Biomedicine and Prevention, Università di Roma "Tor Vergata," Rome, Italy.
  • Ottone T; Department of Biomedicine and Prevention, Università di Roma "Tor Vergata," Rome, Italy.
  • Nomdedeu JF; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Santpau and Jose Carreras Leukemia Research Institutes, Autonomus University of Barcelona, Barcelona, Spain.
  • Mandrekar SJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN.
  • Klisovic RB; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Wei AH; Department of Clinical Hematology, The Alfred Hospital and Monash University, Melbourne, VIC, Australia.
  • Sierra J; Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Santpau and Jose Carreras Leukemia Research Institutes, Autonomus University of Barcelona, Barcelona, Spain.
  • Sanz MA; Instituto de Investigación Sanitaria La Fe, University of Valencia, Valencia, Spain.
  • Brandwein JM; Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid, Spain.
  • de Witte T; Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada.
  • Jansen JH; Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Niederwieser D; Laboratory Hematology, Deptartment of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Appelbaum FR; Department of Hematology, Oncology, and Hemostasis, University of Leipzig, Leipzig, Germany.
  • Medeiros BC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Tallman MS; Division of Hematology, Stanford Comprehensive Cancer Center, Stanford University, Stanford, CA.
  • Schlenk RF; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ganser A; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Serve H; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Ehninger G; Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany.
  • Amadori S; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Gathmann I; Department of Biomedicine and Prevention, Università di Roma "Tor Vergata," Rome, Italy.
  • Benner A; Novartis Pharmaceuticals, Basel, Switzerland; and.
  • Pallaud C; Division of Biostatistics, German Cancer Research Center Heidelberg, Heidelberg, Germany.
  • Stone RM; Novartis Pharmaceuticals, Basel, Switzerland; and.
  • Döhner H; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA.
  • Bloomfield CD; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
Blood ; 135(5): 371-380, 2020 01 30.
Article in En | MEDLINE | ID: mdl-31826241
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Genetic Predisposition to Disease / Gene Duplication / Tandem Repeat Sequences / Fms-Like Tyrosine Kinase 3 Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Genetic Predisposition to Disease / Gene Duplication / Tandem Repeat Sequences / Fms-Like Tyrosine Kinase 3 Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2020 Type: Article